LG / McNeil SA / Mulholland K / Vaxent LLC / McCarty M / Halperin SA / /
Continent
Africa / Asia / Europe / /
Country
United States / Canada / Australia / / /
Event
FDA Phase / /
Facility
University of Tennessee / University of Western Australia Centre / Murdoch Childrens Research Institute / Royal Children’s Hospital / University of Tennessee Health Science Center / University of Melbourne / ‡Telethon Institute / Princess Margaret Hospital / /
IndustryTerm
epidemiologic protocols / large pharmaceutical / safety protocols / GAS pharyngitis / antigenome technology / /
MedicalCondition
GAS impetigo / GAS pharyngitis / uncommon disease / invasive disease / GAS diseases / streptococcal diseases / Childhood post-streptococcal glomerulonephritis / single infectious agent / diphtheria / poststreptococcal glomerulonephritis / chronic renal disease / impetigo / MS / rheumatic heart disease / sepsis / invasive GAS disease / end-stage renal failure / GAS skin infection / acquired heart disease / acute rheumatic fever / disease / particularly rheumatic fever / streptococcal infection / serious GAS diseases / GAS disease / wealthy countries GAS diseases / very common infection / diseases / rheumatic fever / infectious diseases / GAS infections / human disease / /
MedicalTreatment
immunization / immunizations / vaccination / /
Organization
University of Melbourne / Royal Children’s Hospital / World Health Organization / Centre for International / University of Western Australia Centre for Child Health Research / University of Tennessee / ‡Telethon Institute for Child Health Research / Princess Margaret Hospital for Children / Centre for International Child Health / Tennessee Health Science Center / Department of Paediatrics / US Department of Veterans Affairs / Murdoch Childrens Research Institute / /
Person
Andrew C. Steer / James B. Dale / Jonathan R. Carapetis / Rebecca Lancefield / /
Position
advocate / /
Product
C5a / GAS vaccine / /
ProvinceOrState
Western Australia / Victoria / Tennessee / /
PublishedMedium
The Pediatric Infectious Disease Journal / Lippincott Williams & Wilkins / /
ESPID Reports and Reviews Progress Toward a Global Group A Streptococcal Vaccine Andrew C. Steer, PhD,* James B. Dale, PhD,† and Jonathan R. Carapetis PhD‡ RATIONALE FOR GROUP A STREPTOCOCCAL VACCINES